✦ LIBER ✦

Longitudinal changes of fractional anisotropy in Alzheimer’s disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study

✍ Scribed by Y. Likitjaroen, T. Meindl, U. Friese, M. Wagner, K. Buerger, H. Hampel, S. J. Teipel

Book ID: 113040069
Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 445 KB
Volume: 262
Category: Article
ISSN: 1433-8491
DOI: 10.1007/s00406-011-0234-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cessation versus continuation of 12 mont

Cessation versus continuation of 12 months galantamine therapy in patients with Alzheimer's disease: A randomised, double blind, placebo controlled withdrawal trial

✍ Adami, Marina; Scarpini, Elio; Bruno, Guiseppe; Zappala, Guiseppe; Richarz, Ute; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

A double-blind, placebo-controlled, enri

A double-blind, placebo-controlled, enriched population study of tacrine in patients with Alzheimer's disease

✍ F. Forette; T. Hoover; S. Gracon; J. de Rotrou; M.P. Hervy; B. Lechevalier; M. M 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 973 KB

Atomoxetine Augmentation of Cholinestera

Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Patients With Alzheimer Disease: 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Trial Study

✍ Mohs, Richard C.; Shiovitz, Thomas M.; Tariot, Pierre N.; Porsteinsson, Anton P. 📂 Article 📅 2009 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 168 KB

A six-month double-blind, randomized, pl

A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch versus capsule

✍ Bengt Winblad; Jeffrey Cummings; Niels Andreasen; George Grossberg; Marco Onofrj 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

## Abstract ## Objectives To compare the efficacy, safety and tolerability of a novel rivastigmine transdermal patch with conventional rivastigmine capsules and placebo in patients with Alzheimer's disease (AD). ## Methods In this 24‐week, multicenter, double‐blind, double‐dummy, placebo‐ and ac

1-12-10 Nicergoline in the treatment of

1-12-10 Nicergoline in the treatment of probable Alzheimer's disease. Preliminary results of a double-blind, randomized, placebo-controlled study

✍ Thomas H. Crook 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 172 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole for the Treatment of Psychosis in Nursing Home Patients with Alzheimer Disease

✍ Streim, Joel E.; Porsteinsson, Anton P.; Breder, Christopher D.; Swanink, René; 📂 Article 📅 2008 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 305 KB